Dongying Zhang: Clinical Trials

7 trials sponsored by Dongying Zhang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 unknown, 1 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 1, Unknown 1

Follow Dongying Zhang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction
Vericiguat - Heart Failure, Acute Myocardial Infarction (AMI)
Phase 4Not yet recruitingDongying Zhang2002025-04-012025-02-06
Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation
Colchicine 0.5 MG Oral Tablet Once Daily - Heart Failure, Heart Failure With Preserved Ejection Fraction (HFPEF)
Phase 4UnknownDongying Zhang2002024-10-312024-09-19
The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients
Heart Failure With Preserved Ejection Fraction
CompletedDongying Zhang10832020-10-122026-01-06
Relationship Between Ambulatory Arterial Stiffness Index and Left Ventricular Diastolic Function in Patients With HFpEF
Heart Failure With Preserved Ejection Fraction
UnknownDongying Zhang2002020-10-102021-09-28
Role of SGLT2I in Patients With Myocardial Infarction
SGLT2 inhibitor - Myocardial Infarction, Diabetes Mellitus
UnknownDongying Zhang12002018-01-012024-02-08
The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in STEMI Patients After PCI
ST Elevation Myocardial Infarction
CompletedDongying Zhang22015-10-012018-11-14
The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI
ST Elevation Myocardial Infarction
CompletedDongying Zhang32015-10-012019-06-12

Conditions studied

Heart Failure (2)  ·  ST Elevation Myocardial Infarction (2)  ·  Diabetes Mellitus (1)  ·  Inflammation (1)  ·  Myocardial Infarction (1)

Interventions

Colchicine (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  vericiguat (1)

Countries

China (5)

Results publications

PMID 14744970, PMID 22357361, PMID 24621874, PMID 29496021, PMID 31535829, PMID 32222134, PMID 32865380, PMID 34449189, PMID 39211951, PMID 40402390